>
Healthscope logo

HSO - Healthscope Share Price

A$2.46 0.0  0.0%

Last Trade - 24/05/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £1.27bn
Position in Universe th / 1914
Bullish
Bearish
Unlock HSO Revenue
Momentum
Relative Strength (%)
1m -5.63%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
2,212 2,038 2,157 2,233 2,257 2,341 2,659 3,084 +1.1%
+21.5 -12.5 -35.6 +42.3 +25.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2018,Healthscope Ltd revenues increased 3% to A$1.22B. Netincome before extraordinary items decreased 7% to A$66.9M.Revenues reflect Hospitals Australia segment increase of 3%to A$1.1B, Pathology New Zealand segment increase of 3% toA$122.8M. Net income was offset by Employee benefitsexpense increase of 2% to A$556.5M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

HSO Revenue Unlock HSO Revenue

Net Income

HSO Net Income Unlock HSO Revenue

Normalised EPS

HSO Normalised EPS Unlock HSO Revenue

PE Ratio Range

HSO PE Ratio Range Unlock HSO Revenue

Dividend Yield Range

HSO Dividend Yield Range Unlock HSO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
HSO EPS Forecasts Unlock HSO Revenue
Profile Summary

Healthscope Ltd is an Australia-based company that provides private healthcare services. The Company operates through approximately 43 private hospitals in Australia and pathology operations across New Zealand. Its services include maternity services, medical and surgical services, mental health services, rehabilitation services and emergency department. Its Healthscope Independence Services (HIS) is a provider of accommodation, attendant care and in-home services to individuals with acquired brain injuries, disabilities, complex conditions and those who have left hospital and require additional support at home. The services provided by HIS includes attendant care, post-hospital care and residential care. Its Healthscope International Pathology has operations across New Zealand with approximately 24 laboratories and over 140 collection centers. It also provides veterinary and analytical pathology services throughout New Zealand.

Directors
Last Annual June 30th, 2018
Last Interim December 31st, 2018
Incorporated June 25, 2010
Public Since July 28, 2014
No. of Shareholders: 31,795
No. of Employees: 18,000
Sector Healthcare
Industry Healthcare Providers & Services
Index FTSE Developed Asia Pacific , FTSE Developed Asia Pacific Ex Japan ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 1,741,161,795
Free Float (0.0%)
Eligible for
ISAs
SIPPs
HSO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for HSO
Upcoming Events for HSO
Frequently Asked Questions for Healthscope
What is the Healthscope share price?

As of 24/05/19, shares in Healthscope are trading at A$2.46, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Healthscope share price performed this year?

Shares in Healthscope are currently trading at A$2.46 and the price has moved by 4.68% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Healthscope price has moved by -16.91% over the past year.

What are the analyst and broker recommendations for Healthscope?

Of the analysts with advisory recommendations for Healthscope, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Healthscope is Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Healthscope next release its financial results?

Healthscope is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-12-31
What is the Healthscope dividend yield?

The Healthscope dividend yield is % based on the trailing twelve month period.

Does Healthscope pay a dividend?

Last year, Healthscope paid a total dividend of 0.07, and it currently has a trailing dividend yield of %. Looking ahead, Healthscope has not announced an ex-dividend date yet.

When does Healthscope next pay dividends?

Healthscope has yet to annouce their ex-dividend date. The historic dividend yield on Healthscope shares is currently %.

How do I buy Healthscope shares?

To buy shares in Healthscope you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Healthscope?

Shares in Healthscope are currently trading at A$2.46, giving the company a market capitalisation of £n/a.

Where are Healthscope shares listed? Where are Healthscope shares listed?

Here are the trading details for Healthscope:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: HSO
What kind of share is Healthscope?

We were not able to load our ranking data for Healthscope

Is there a Healthscope share price forecast 2021?

We were not able to load any forecast data for Healthscope.

How can I tell whether the Healthscope share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Healthscope. Over the past six months, the relative strength of its shares against the market has been 0.12%. At the current price of A$2.46, shares in Healthscope are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Healthscope PE Ratio?

We were not able to find PE ratio data for Healthscope.

Who are the key directors of Healthscope?

We were unable to find the directors for Healthscope.

Who are the major shareholders of Healthscope?

Here are the top five shareholders of Healthscope based on the size of their shareholding:

Similar to HSO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.